12-2237227-C-T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1

The NM_000719.7(CACNA1C):​c.477+116797C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.354 in 152,012 control chromosomes in the GnomAD database, including 10,219 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.35 ( 10219 hom., cov: 32)

Consequence

CACNA1C
NM_000719.7 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.486

Publications

29 publications found
Variant links:
Genes affected
CACNA1C (HGNC:1390): (calcium voltage-gated channel subunit alpha1 C) This gene encodes an alpha-1 subunit of a voltage-dependent calcium channel. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization. The alpha-1 subunit consists of 24 transmembrane segments and forms the pore through which ions pass into the cell. The calcium channel consists of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. There are multiple isoforms of each of these proteins, either encoded by different genes or the result of alternative splicing of transcripts. The protein encoded by this gene binds to and is inhibited by dihydropyridine. Alternative splicing results in many transcript variants encoding different proteins. Some of the predicted proteins may not produce functional ion channel subunits. [provided by RefSeq, Oct 2012]
CACNA1C Gene-Disease associations (from GenCC):
  • Timothy syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • neurodevelopmental disorder with hypotonia, language delay, and skeletal defects with or without seizures
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics
  • long QT syndrome
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • long QT syndrome 8
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Brugada syndrome
    Inheritance: AD Classification: SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, ClinGen
  • Brugada syndrome 3
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
  • intellectual disability
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • short QT syndrome
    Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Ambry Genetics, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 12-2237227-C-T is Benign according to our data. Variant chr12-2237227-C-T is described in ClinVar as Benign. ClinVar VariationId is 1168308.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.472 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1CNM_000719.7 linkc.477+116797C>T intron_variant Intron 3 of 46 ENST00000399655.6 NP_000710.5 Q13936-12
CACNA1CNM_001167623.2 linkc.477+116797C>T intron_variant Intron 3 of 46 ENST00000399603.6 NP_001161095.1 Q13936-37

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1CENST00000399603.6 linkc.477+116797C>T intron_variant Intron 3 of 46 5 NM_001167623.2 ENSP00000382512.1 Q13936-37
CACNA1CENST00000399655.6 linkc.477+116797C>T intron_variant Intron 3 of 46 1 NM_000719.7 ENSP00000382563.1 Q13936-12
CACNA1CENST00000682544.1 linkc.567+116797C>T intron_variant Intron 3 of 49 ENSP00000507184.1 A0A804HIR0
CACNA1CENST00000406454.8 linkc.477+116797C>T intron_variant Intron 3 of 47 5 ENSP00000385896.3 F5GY28
CACNA1CENST00000399634.6 linkc.477+116797C>T intron_variant Intron 3 of 46 5 ENSP00000382542.2 E9PDI6
CACNA1CENST00000683824.1 linkc.567+116797C>T intron_variant Intron 3 of 47 ENSP00000507867.1 A0A804HKC4
CACNA1CENST00000347598.9 linkc.477+116797C>T intron_variant Intron 3 of 48 1 ENSP00000266376.6 Q13936-11
CACNA1CENST00000344100.7 linkc.477+116797C>T intron_variant Intron 3 of 46 1 ENSP00000341092.3 Q13936-14
CACNA1CENST00000327702.12 linkc.477+116797C>T intron_variant Intron 3 of 47 1 ENSP00000329877.7 A0A0A0MR67
CACNA1CENST00000399617.6 linkc.477+116797C>T intron_variant Intron 3 of 47 5 ENSP00000382526.1 A0A0A0MSA1
CACNA1CENST00000682462.1 linkc.567+116797C>T intron_variant Intron 3 of 46 ENSP00000507105.1 A0A804HIJ8
CACNA1CENST00000683781.1 linkc.567+116797C>T intron_variant Intron 3 of 46 ENSP00000507434.1 A0A804HJB6
CACNA1CENST00000683840.1 linkc.567+116797C>T intron_variant Intron 3 of 46 ENSP00000507612.1 A0A804HJR1
CACNA1CENST00000683956.1 linkc.567+116797C>T intron_variant Intron 3 of 46 ENSP00000506882.1 A0A804HI37
CACNA1CENST00000399638.5 linkc.477+116797C>T intron_variant Intron 3 of 47 1 ENSP00000382547.1 Q13936-31
CACNA1CENST00000335762.10 linkc.477+116797C>T intron_variant Intron 3 of 47 5 ENSP00000336982.5 F5H522
CACNA1CENST00000399606.5 linkc.477+116797C>T intron_variant Intron 3 of 47 1 ENSP00000382515.1 Q13936-30
CACNA1CENST00000399621.5 linkc.477+116797C>T intron_variant Intron 3 of 46 1 ENSP00000382530.1 Q13936-24
CACNA1CENST00000399637.5 linkc.477+116797C>T intron_variant Intron 3 of 46 1 ENSP00000382546.1 Q13936-27
CACNA1CENST00000402845.7 linkc.477+116797C>T intron_variant Intron 3 of 46 1 ENSP00000385724.3 Q13936-13
CACNA1CENST00000399629.5 linkc.477+116797C>T intron_variant Intron 3 of 46 1 ENSP00000382537.1 Q13936-32
CACNA1CENST00000682336.1 linkc.477+116797C>T intron_variant Intron 3 of 46 ENSP00000507898.1 A0A804HKE9
CACNA1CENST00000399591.5 linkc.477+116797C>T intron_variant Intron 3 of 45 1 ENSP00000382500.1 Q13936-29
CACNA1CENST00000399595.5 linkc.477+116797C>T intron_variant Intron 3 of 45 1 ENSP00000382504.1 Q13936-25
CACNA1CENST00000399649.5 linkc.477+116797C>T intron_variant Intron 3 of 45 1 ENSP00000382557.1 Q13936-15
CACNA1CENST00000399597.5 linkc.477+116797C>T intron_variant Intron 3 of 46 1 ENSP00000382506.1 Q13936-22
CACNA1CENST00000399601.5 linkc.477+116797C>T intron_variant Intron 3 of 46 1 ENSP00000382510.1 Q13936-20
CACNA1CENST00000399641.6 linkc.477+116797C>T intron_variant Intron 3 of 46 1 ENSP00000382549.1 Q13936-23
CACNA1CENST00000399644.5 linkc.477+116797C>T intron_variant Intron 3 of 46 1 ENSP00000382552.1 Q13936-21
CACNA1CENST00000682835.1 linkc.477+116797C>T intron_variant Intron 3 of 46 ENSP00000507282.1 A0A804HIZ0
CACNA1CENST00000683482.1 linkc.477+116797C>T intron_variant Intron 3 of 46 ENSP00000507169.1 Q13936-35
CACNA1CENST00000682686.1 linkc.477+116797C>T intron_variant Intron 3 of 45 ENSP00000507309.1 Q13936-19
CACNA1CENST00000682152.1 linkc.426+116797C>T intron_variant Intron 2 of 5 ENSP00000506759.1 A0A804HHT8
CACNA1CENST00000480911.6 linkn.477+116797C>T intron_variant Intron 3 of 26 5 ENSP00000437936.2 F5H638

Frequencies

GnomAD3 genomes
AF:
0.354
AC:
53760
AN:
151896
Hom.:
10224
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.478
Gnomad AMI
AF:
0.313
Gnomad AMR
AF:
0.286
Gnomad ASJ
AF:
0.294
Gnomad EAS
AF:
0.0507
Gnomad SAS
AF:
0.246
Gnomad FIN
AF:
0.319
Gnomad MID
AF:
0.231
Gnomad NFE
AF:
0.335
Gnomad OTH
AF:
0.327
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.354
AC:
53793
AN:
152012
Hom.:
10219
Cov.:
32
AF XY:
0.348
AC XY:
25883
AN XY:
74294
show subpopulations
African (AFR)
AF:
0.478
AC:
19793
AN:
41444
American (AMR)
AF:
0.286
AC:
4367
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.294
AC:
1021
AN:
3468
East Asian (EAS)
AF:
0.0505
AC:
261
AN:
5172
South Asian (SAS)
AF:
0.247
AC:
1190
AN:
4816
European-Finnish (FIN)
AF:
0.319
AC:
3369
AN:
10562
Middle Eastern (MID)
AF:
0.241
AC:
71
AN:
294
European-Non Finnish (NFE)
AF:
0.335
AC:
22756
AN:
67956
Other (OTH)
AF:
0.323
AC:
680
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1729
3458
5187
6916
8645
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
524
1048
1572
2096
2620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.328
Hom.:
35485
Bravo
AF:
0.353
Asia WGS
AF:
0.150
AC:
524
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Long QT syndrome Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.86
DANN
Benign
0.61
PhyloP100
-0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2159100; hg19: chr12-2346393; API